The largest database of trusted experimental protocols

30 protocols using nicotine bitartrate

1

Nicotine Bitartrate Administration Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nicotine bitartrate (Sigma Chemical Co., St. Louis, MO) was dissolved into sterile saline. The pH of the solution was adjusted to 7.4 with dilute NaOH, and heparin (30 units/ml) was added to help maintain catheter patency. Nicotine doses are expressed as the base. Methohexital (Sigma Chemical Co., St. Louis, MO) was dissolved in sterile saline (0.1ml, 10 mg/ml, i.v.) and used to assess catheter patency.
+ Open protocol
+ Expand
2

Nicotine and Mecamylamine Dissolution and Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nicotine bitartrate and mecamylamine (MEC) were obtained from Sigma Chemical Co. (St. Louis, MO) and dissolved in sterile saline. Whole Tobacco Alkaloid (WTA) EC refill liquid (Dark Honey Tobacco flavor in 10 ml vials) was obtained from Aroma E-Juice (http://www.aromaejuice.com, Scottsdale, AZ). According to the label, the refill liquid contained 80% vegetable glycerine (VG) and 20% propylene glycol (PG), and had a nicotine concentration of 24 mg/ml. The nicotine concentration was determined in each 10 ml vial of EC liquid used (see below), allowing dilution in saline to the nicotine concentrations required for the current studies. The pH of the solutions was adjusted to 7.4 with dilute NaOH or HCL, and heparin (30 units/ml) was added to help maintain catheter patency for the self-administration study. Nicotine and mecamylamine doses are expressed as the base and salt, respectively.
+ Open protocol
+ Expand
3

Synthesis and Characterization of m-bromo PEP

Check if the same lab product or an alternative is used in the 5 most similar protocols
1-ethyl-4-(3-(bromo)phenyl)piperazine (m-bromo PEP; See Suppl. Fig. 1) was synthesized as described previously [29 (link)]. PNU-120596 was synthesized following the published procedure [45 ]. Fresh acetylcholine (ACh; Sigma-Aldrich, Saint-Louis, MO, USA) stock solutions were made each day of experimentation. PNU-120596 and m-bromo PEP stock solutions were prepared in dimethylsulfoxide (DMSO) (Sigma-Aldrich) and stored at −20 °C. Nicotine bitartrate (Sigma-Aldrich), mecamylamine (Tocris Bioscience, Bristol, UK), α-bungarotoxin (αBgt; Tocris), AR-R17779 (Tocris), recombinant human M-CSF (Sigma-Aldrich) and IFNγ (Cell Guidance Systems, Cambridge, UK) were prepared in PBS, stored at −20 °C. All working drug solutions were prepared fresh each day at the desired concentration from the stored stock. All doses are expressed as the free base of the drug.
+ Open protocol
+ Expand
4

Continuous Nicotine Delivery in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
As described previously (11 (link)), nicotine bitartrate (Sigma-Aldrich, St.Louis, MO, USA) in phosphate-buffered saline (PBS) (100mg/ml) or a solution containing PBS alone was freshly prepared and loaded into Alzet osmotic minipumps (model 1007D and model 2002, DurectCorporation, Cupertino, CA, USA) 12 hours before pump implantation. The pumps were implanted subcutaneously on the back of the mice and continuously delivered either PBS or nicotine salt at 0.39 mg of nicotine free base per mouse per day until the indicated days for sacrifice (7d, 12d, 16d or 22d). The pump implantation surgeries were done 2 days before MOG immunization.
+ Open protocol
+ Expand
5

Intravenous Nicotine Self-Administration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nicotine hydrogen tartrate salt (nicotine bitartrate, Sigma, Natick, MA, USA) was dissolved in 0.9% saline (pH 7.4) and self-administered via an indwelling intravenous jugular catheter (0.03 mg/kg/100 µL infusion). Nicotine salt is preferred to the free base form for more stable storage and use during the experiments. Doses reported in this study are expressed as the free base concentrations.
+ Open protocol
+ Expand
6

Synthesis and Characterization of m-bromo PEP

Check if the same lab product or an alternative is used in the 5 most similar protocols
1-ethyl-4-(3-(bromo)phenyl)piperazine (m-bromo PEP; See Suppl. Fig. 1) was synthesized as described previously [29 (link)]. PNU-120596 was synthesized following the published procedure [45 ]. Fresh acetylcholine (ACh; Sigma-Aldrich, Saint-Louis, MO, USA) stock solutions were made each day of experimentation. PNU-120596 and m-bromo PEP stock solutions were prepared in dimethylsulfoxide (DMSO) (Sigma-Aldrich) and stored at −20 °C. Nicotine bitartrate (Sigma-Aldrich), mecamylamine (Tocris Bioscience, Bristol, UK), α-bungarotoxin (αBgt; Tocris), AR-R17779 (Tocris), recombinant human M-CSF (Sigma-Aldrich) and IFNγ (Cell Guidance Systems, Cambridge, UK) were prepared in PBS, stored at −20 °C. All working drug solutions were prepared fresh each day at the desired concentration from the stored stock. All doses are expressed as the free base of the drug.
+ Open protocol
+ Expand
7

Nicotinic Alkaloid Administration Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
(−)-Nicotine bitartrate, (+/−) nornicotine, (+/−) anabasine, (+/−) myosmine, and (−)-cotinine were obtained from Sigma (St Louis, MO). (+/−) Anatabine was obtained from Toronto Research Chemicals, Inc. (Ontario, Canada). All drugs were prepared in sterile saline, adjusted to a pH of 7.4 using dilute NaOH, and administered s.c. in a volume of 1 ml/kg. All drug doses are expressed as the base.
+ Open protocol
+ Expand
8

Nicotine Self-Administration Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nicotine bitartrate (Sigma-Aldrich) was dissolved in 0.9% sterile saline (pH 7.4) and passed through a microfilter. A low dose (5 μg/kg/infusions) of nicotine was selected based on previous work demonstrating that this dose engenders rapid rates of acquisition, high levels of self-administration under extended access conditions, and robust levels of subsequent nicotine-seeking following 10 days of abstinence (Sanchez et al., 2013 (link); 2014 (link)). The dose is expressed as the free base weight and infusions were delivered at a rate of 0.1 ml/sec based on the animal’s weight. Nicotine solution was stored at 4 °C but was available at room temperature during self-administration sessions.
+ Open protocol
+ Expand
9

Nicotine and Mecamylamine Delivery Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nicotine bitartrate and mecamylamine hydrochloride (Sigma Chemical Co., St. Louis, MO) were dissolved in sterile saline. The pH of the nicotine solution was adjusted to 7.4 with dilute NaOH. Nicotine doses are expressed as the base. Nicotine was administered via osmotic minipump (see below). Mecamylamine was administered via s.c. injection at a volume of 1.0 ml/kg.
+ Open protocol
+ Expand
10

Naltrexone Effects on Substance Preferences

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cocaine hydrochloride was received from the NIDA Drug Supply Program, nicotine bitartrate was purchased from Sigma Aldrich (St. Louis, MO, United States), and varenicline tartrate was purchased from Biotang (Lexington, MA, United States). Vehicle (0.97 mM HCl; salt equivalent of naltrexone HCl) and naltrexone HCl (N-3136; FW 377.9; Sigma-Aldrich) were used to pretreat animals prior to SOA preference testing. Benzaldehyde (#418099; 99.5%; Sigma-Aldrich; FW 106.12) was used to test for non-selective effects of naltrexone HCl. 2-nonanone (99%; CAS 821-55-6; FW 142.24; Arcos Organics) was used to show that animals could move away from the SOA target zone.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!